EQMICRO

Equillium, Inc.

HealthcareBiotechnology
$2.88
$0.00(+3.97%)
52W$0.29
$3.54
Updated Jul 8, 02:00 AM
RSI48
RS Rating94/99
Beta0.41
Volatility164%
F-Score1/9
Mkt Cap$277M
STAGE 2 UPTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

STAGE 2 UPTREND

Equillium, Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 94), indicating clear outperformance against the broad market. Earnings growth of 77% provides fundamental context to the price action. Investors should exercise caution due to high volatility (164% annualized), which requires wider risk management.

Relative Strength
94
out of 99
Market Leader
Trend Score
4/4
Minervini Criteria
STAGE 2 UPTREND
Risk (Beta)
0.41
vs S&P 500
LOW VOL
52W Position
80%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

STAGE 2 UPTREND4/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$2.57
50 SMA > 100 SMA$2.25
100 SMA > 150 SMA$1.92
150 SMA > 200 SMA$1.76

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$2.89-0.31%BELOW
50 SMA$2.57+12.21%ABOVE
100 SMA$2.25+27.98%ABOVE
150 SMA$1.92+50.28%ABOVE
200 SMA$1.76+63.83%ABOVE

Price Performance

1D+4.0%
1W-10.0%
1M+4.0%
3M+50.0%
6M+119.8%
YTD+88.2%
1Y+8.0%
3Y+47.4%
52-Week Trading Range80% from low
$2.88
52W Low$0.29
52W High$3.54

Technical Indicators

RSI (14)NEUTRAL
48.4
305070
Setup ScoreCOOL
3/10
Base depth: 64.1%

Risk Profile

Beta
0.41
52W Vol
164%
ATR
$0.26
Max DD (1Y)
-58%

Volume Analysis

Today
351.6K
50D Avg
704.7K
Vol Ratio
0.50x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25-1350%
$-0.16
Q3'25-59900%
$-0.12
Q4'25+74%
$-0.04
Q1'26+77%
$-0.06
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:-100.00%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+2.87%

Stock Price CAGR

10 Years:-14.63%
5 Years:-12.20%
3 Years:+47.36%
1 Year:+8.03%

Return on Equity

10Y Avg:-63.7%
5Y Avg:-73.1%
3Y Avg:-60.6%
Last Year:-61.4%

Key Metrics

Market Cap$277M
Gross Margin
Net Margin
Piotroski F-Score1/9

Frequently Asked Questions

Is EQ in an uptrend right now?

EQ has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, EQ is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.

Is EQ overbought or oversold?

EQ's RSI (14) is 48. The stock is in neutral territory, neither overbought nor oversold.

Is EQ outperforming the market?

EQ has a Relative Strength (RS) Rating of 94 out of 99. Yes, EQ is a market leader, outperforming 94% of all stocks over the past 12 months.

Where is EQ in its 52-week range?

EQ is trading at $2.88, which is 81% of its 52-week high ($3.54) and 80% above its 52-week low ($0.29).

How volatile is EQ?

EQ has a Beta of 0.41 and 52-week volatility of 164%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.